Novel imaging strategies for the detection of prosthetic heart valve obstruction and endocarditis by unknown
Review ARticle
Published online: 7 January 2016
© The Author(s) 2016. This article is published with open access at Springerlink.com
Novel imaging strategies for the detection of prosthetic heart 
valve obstruction and endocarditis
W. Tanis · R.P.J. Budde · I.A.C. van der Bilt · B. Delemarre · G. Hoohenkerk ·  
J.-K. van Rooden · A.M. Scholtens · J. Habets · S. Chamuleau
Neth Heart J (2016) 24:96–107
DOI 10.1007/s12471-015-0796-0
tion, additional imaging is not beneficial as it does not 
change patient management. When performed on top of 
2D-TTE/TEE, MDCT has additional value for the detec-
tion of both vegetations and pseudoaneurysms/abscesses 
in PHV endocarditis. FDG-PET has no complementary 
value for the detection of vegetations; however, it appears 
more sensitive in the early detection of pseudoaneurysms/
abscesses. Furthermore, FDG-PET enables the detection of 
metastatic and primary extra-cardiac infections. Evidence 
for the additional value of 3D-TEE is scarce.
As clinical implications are major, clinicians should 
have a low threshold to perform additional MDCT in ac-
quired mechanical PHV obstruction. For suspected PHV 
endocarditis, both FDG-PET and MDCT have complemen-
tary value.
Keywords Prosthetic heart valve · Endocarditis · 
Thrombosis · Pannus · Multidetector-row computed 
tomography · 18-fluorine-fluorodesoxyglucose positron 
emission tomography
Introduction
Valvular heart disease often requires prosthetic heart valve 
(PHV) replacement in order to improve quality of life and 
survival. The number of PHV implantations is expected 
to rise due to ageing, the growth of the population and the 
development of catheter-based techniques for valve replace-
ment in patients who were inoperable before these tech-
niques emerged. The major drawback of both mechanical 
and biological PHVs is development of dysfunction that 
is accompanied by high morbidity and mortality [1]. The 
reported incidence of PHV dysfunction varies from 0.01 
to  6.0 % per patient-year and is dependent on valve posi-
Abstract Prosthetic heart valve (PHV) dysfunction re-
mains difficult to recognise correctly by two-dimensional 
(2D) transthoracic and transoesophageal echocardiography 
(TTE/TEE). ECG-triggered multidetector-row computed 
tomography (MDCT), 18-fluorine-fluorodesoxyglucose 
positron emission tomography including low-dose CT 
(FDG-PET) and three-dimensional transoesophageal echo-
cardiography (3D-TEE) may have additional value. This 
paper reviews the role of these novel imaging tools in the 
field of PHV obstruction and endocarditis.
For acquired PHV obstruction, MDCT is of additional 
value in mechanical PHVs to differentiate pannus from 
thrombus as well as to dynamically study leaflet motion 
and opening/closing angles. For biological PHV obstruc-
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tion, valve composition, patient characteristics, patient 
compliance (endocarditis prophylaxis and anticoagulation 
in mechanical valves) and the nature of dysfunction. Causes 
of PHV dysfunction can be divided into three main groups 
that can be subsets of each other: (1) paravalvular leakage, 
(2) endocarditis and (3) obstruction [2].
As symptoms may be non-specific, echocardiography of 
PHVs plays a pivotal role and guides the therapeutic regi-
men. However, acoustic shadowing and reverberation of the 
metal of the PHVs hamper reliable imaging by transthoracic 
and transoesophageal echocardiography (TTE and TEE). 
For the detection of PHV leakages (not in the context of 
endocarditis) the combination of TTE and TEE has a high 
diagnostic accuracy for severity and location (valvular/
paravalvular) and diagnostic dilemmas are mostly solved 
[3–6]. PHV endocarditis and obstruction often raise more 
diagnostic problems even after performing 2D-TTE/TEE 
[2]. Therefore the objective of this article is to review the 
additional value of new imaging modalities in the field of 
PHV endocarditis and obstruction. The diagnostic role of 
multidetector-row computed tomography (MDCT), 18-flu-
orine-fluorodesoxyglucose positron emission tomography 
including low dose CT (FDG-PET) and three-sdimensional 
TEE (3D-TEE) will be discussed. A diagnostic flowchart 
is provided that can aid in determining when and which 
modality to use in the clinical work-up of PHV endocarditis 
and PHV obstruction.
PHV endocarditis
PHV endocarditis occurs with an incidence of 0.3–1.2 % 
per patient-year and is complicated by periannular exten-
sions (pseudoaneurysms and abscesses) in at least 50 % of 
cases [7–9]. This is associated with an in-hospital mortality 
of 30 %, which may even rise to 50 % when Staphylococcus 
aureus is the causative bacterial agent [8–11]. The modified 
Duke criteria may have additional value in the establish-
ment of the diagnosis of PHV endocarditis ([12]; Table 1). 
However, compared with native valve endocarditis, for sus-
pected PHV endocarditis the two major Duke criteria are 
less reliable as the first major criterion (blood cultures) is 
often negative (23–37 %) and the second major criterion 
(echocardiography) is hampered by acoustic shadowing and 
reverberations [8, 10, 11].
The diagnostic value of TTE and TEE has recently been 
systematically reviewed and meta-analysed [2]. TEE was 
significantly more sensitive compared with TTE for the 
detection of vegetations (82 versus 29 %) and periannular 
extensions (86 versus 36 %) [2]. Although TEE detects the 
majority of signs of PHV endocarditis, the main finding of 
this study is that TEE misses the presence of vegetations 
(18 %) and periannular extensions (14 %) compared with the 
reference standard (i.e. surgical inspection/autopsy or clini-
cal follow-up). Thus, ruling out PHV endocarditis by echo-
cardiography incorporates uncertainty, clinically resulting 
in a low threshold to administer antibiotics for a prolonged 
period. On the other hand, periannular abscesses and pseu-
doaneurysms should not be missed as this is an indication 
for urgent surgical intervention.
Novel imaging strategies for PHV endocarditis
Multidetector-row computed tomography
MDCT has recently emerged as a promising novel imaging 
technique to evaluate PHVs. The technique uses electrocar-
diographic (ECG) gating to overcome artefacts related to 
Table 1 Modified Duke criteria for infective prosthetic heart valve en-
docarditis; in bold: the suggested change of the modified Duke criteria
Major criteria
1. Blood cultures positive
*Typical microorganism from two separate blood cultures:
Streptococcus viridans, Streptococcus bovis, HACEK Group, 
Staphylococcus aureus; community-acquired enterococci, in ab-
sence of a primary focus or
*Microorganism from persistently positive blood cultures:
At least two positive blood cultures drawn > 12 h apart or all of 
three or a majority of ≥ four separate cultures positive with the first 
and last drawn at least 1 h apart or
*Single positive blood culture for Coxiella burnetii or phase 1 IgG 
antibody titre > 1:800
2. Imaging
*Echocardiography: positive signs for infective endocarditis (veg-
etation, leaflet perforation, abscess, new partial dehiscence of the 
PHV)
*Molecular imaging (FDG−PET or leucocyte scan): for the detec-
tion of periannular infiltration
*Computed tomography: for the detection of periannular infiltration 
and/or vegetations
Minor criteria
*Predisposition: predisposing heart condition such as PHV or injec-
tion drug use
*Fever: temperature > 38 °C
*Vascular phenomena: major arterial emboli, septic pulmonary 
infarcts, mycotic aneurysm, intracranial haemorrhages, Janeway 
lesions
*Immunological phenomena: glomeronephritis, Osler’s nodes, 
Roth’s spots, rheumatoid factor
*Microbiological evidence: positive blood culture that does not 
meet the major criterion
Definite diagnosis of infective endocarditis
2 major criteria
1 major and 3 minor criteria
5 minor criteria
Possible diagnosis of infective endocarditis
1 major and 1 minor criteria
3 minor criteria
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with MDCT [13–15]. These studies provide a strong indica-
tion that the diagnostic accuracy is improved when MDCT 
is added to TEE in the diagnostic workup (Fig. 1, 2). In 
one of the studies addition of MDCT resulted in a major 
diagnostic change in 6/28 patients (21 %), mainly driven by 
the novel detection of mycotic aneurysms [13]. Compared 
with the routine clinical work-up including TTE/TEE, addi-
tion of MDCT also resulted in a treatment change in seven 
patients (25 %). Therefore MDCT imaging has to be consid-
ered after clinical routine workup including TEE in patients 
with (suspected) PHV endocarditis.
the movement of the heart during the cardiac cycle. Recon-
struction of the retrospectively ECG-gated acquired images 
provides 3D assessment of the PHV in any plane in each 
phase of the heart cycle. The acquisition is performed after 
the administration of contrast material. However, a non-
contrast enhanced scan may have additional value to dis-
criminate suture pledgets and calcifications of the PHV and 
can be performed using prospective ECG triggering in a 
single phase of the cardiac cycle. Contrast enhanced MDCT 
may detect PHV thrombi, pannus, vegetations, paravalvu-
lar leakages, mycotic aneurysms and even abscesses. In the 
field of PHV endocarditis three studies have been performed 
Fig. 2 Pseudoaneurysm missed 
by TEE. Patient with an aortic 
mechanical prosthesis implanted 
2 years before, presented with 
a Proprionii acnes bacteraemia. 
TEE missed the periannular 
extension (arrows)
 
Fig. 1 Vegetations missed by TEE. Patient with an aortic biopros-
thesis for 3 years, presented with an infection of a knee replacement 
prosthesis (streptococcus). Blood cultures remained negative and TEE 
revealed no abnormalities (Panel a and d). CTA however detected hy-
podense masses (panel b and e, arrows) fitting with vegetations, which 
were successfully treated with 6 weeks of intravenous antibiotic treat-
ment (panel c and f)
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motion of the valve leaflets and vegetations resulting in 
blurring of the PET signal beyond the point of detectability. 
Other contributing causes of missing vegetations may be 
the low spatial resolution of PET imaging, the background 
activity of the blood pool and/or direct exposure of vegeta-
tions to antibiotics in the bloodstream which make them 
more prone to be sterilised [19]. For this reason FDG-PET 
should always be combined with an imaging tool with bet-
ter spatial resolution (TEE and/or MDCT) [20]. Combining 
MDCT and FDG-PET results in state-of-the-art high resolu-
tion anatomical and metabolic imaging of the PHV and its 
surrounding anatomy, which seems to be the desired imag-
ing strategy in patients with high suspicion of PHV endo-
carditis but negative/inconclusive echocardiography ([20]; 
Fig. 4). Theoretically, the specificity of FDG-PET may be 
a concern as normal FDG uptake pattern in non-infected 
PHVs is poorly investigated. Especially in the early postop-
erative phase (< 1 year) healing and repair mechanisms may 
be a major issue and could result in false-positive imaging. 
Two small reports were published on the FDG uptake in 
non-infected PHVs [20, 21]. The results suggest that even 
in the early postoperative phase (from 6 weeks after PHV 
implantation) FDG-PET can be used as a diagnostic tool 
to rule out abscesses/pseudoaneurysms. Besides the detec-
tion of infection around PHVs, FDG-PET has an additional 
advantage as whole body PET is also able to detect extra-
FDG-PET
FDG-PET is another imaging technique which is potentially 
useful in the diagnostic workup of these patients since it 
provides metabolic instead of anatomical information. PET 
scanning is based on the detection of annihilation photons 
released when the radionuclide 18 fluorine (18F) emits 
positrons. Unlike glucose, 18F-FDG is not metabolised but 
trapped in the human cell. Infected cells increase glucose 
consumption, resulting in accumulation of 18F-FDG [16]. 
However, cardiac myocytes have a relatively high glucose 
uptake compared with cells in other organs; therefore, it is 
important to force the heart to switch to fatty acid metabo-
lism. This can be accomplished by a 24-hour low carbo-
hydrate diet (last 12 h fasting). When heparin is infused 
(15 min before FDG administration) noninfected myocar-
dial cells have even less FDG uptake [17]. As a result only 
infected cells take up 18F-FDG (Fig. 3). Recently, Saby et al. 
showed that the sensitivity and specificity of FDG-PET for 
PHV endocarditis was 73 and 80 % respectively [18]. How-
ever, when FDG-PET was added as a new major criterion to 
the modified Duke criteria (which includes TTE/TEE), the 
sensitivity rose from 70 to 97 %. The study also showed that 
FDG-PET alone missed a substantial number of vegetations 
(9/20, 45 %) in cases with no other echocardiographic signs 
of PHV endocarditis [18]. Most probably this is caused by 
Fig. 3 Case versus Control. Panel 
a and b: Aortic bileaflet mechani-
cal PHV implanted 16 months 
previously, multiple blood cul-
tures were positive for Proprionii 
bacterium. TTE and TEE did not 
show abnormalities and modified 
Duke criteria were not fulfilled. 
FDG-PET (a) showed severe 
FDG uptake. After fusion with 
MDCT, the FDG uptake was 
detected around the PHV ring (b), 
suggestive of widespread perian-
nular extension of endocarditis 
around the whole PHV, which 
was confirmed at subsequent 
surgical inspection and pathologi-
cal examination. Panel c and d: 
Aortic bileaflet St. Jude prosthesis 
in the chronic postoperative phase 
without suspected endocarditis. 
Metabolic imaging by FDG-PET 
on the level of the PHV did not 
show uptake. Re-printed with 
permission [20]
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very early postoperative episode and in case of inconclusive 
FDG-PET, leucocyte SPECT scanning could be considered 
[23].
Three-dimensional TEE
A major drawback of additional techniques such as MDCT 
and nuclear imaging is that they are expensive, expose 
patients to radiation and in case of MDCT iodinated con-
trast is administered. The use of contrast is relatively con-
traindicated when PHV endocarditis is complicated by renal 
failure. In most modern echo labs 3D-TEE is available for 
valve evaluation (anatomy) and guidance of treatment (e.g. 
TAVI, Mitraclip). This 3D technique may also be beneficial 
for detection of PHV endocarditis. 3D-TEE is performed 
with a multiplane probe including a 3D matrix-array. 3D 
full-volume datasets allow offline image editing using the 
multiple plane reconstruction mode and freehand cropping 
mode [24, 25]. This provides wide-angled 3D datasets with 
the ability to manipulate and crop images not limited to 
conventional 2D planar views. It enables visualisation of 
PHV valves with vegetations and periannular extensions, 
cardiac primary foci and/or metastatic infections (Fig. 4). In 
several studies metastatic/primary extra-cardiac infections 
were found in around 40 % of PHV endocarditis cases [22], 
resulting in major therapeutic consequences.
Leucocyte scan
Single photon emission computed tomography (SPECT) is 
a 3D nuclear imaging technique. When using radioactively 
labelled leucocytes as the tracer it can be applied for the 
detection of infection. Images are obtained from multiple 
angles and are reconstructed in 3D. The study by Hyafil et 
al. investigated the additional value of detection of perival-
vular infection in patients with a suspicion of PHV endo-
carditis and inconclusive TEE [23]. Diagnostic accuracy 
was not investigated; however in 12 out of 42 cases SPECT 
resulted in a change in patient management. Although 
labelled leucocyte SPECT/CT is much more time consum-
ing and less sensitive compared with FDG-PET, SPECT is 
more specific especially in the early postoperative period. 
FDG-PET seems to be preferable as clinical implementation 
is easier and spatial resolution is superior. However, in the 
Fig. 4 Metastatic infection in 
PHV endocarditis detected by 
whole body FDG-PET/low-dose 
CT. Bileaflet mechanical PHV in 
aortic position for 6 years, and 
seven consecutive blood cultures 
with Streptococcus pneumoniae. 
a TEE showed a vegetation 
(arrow) and thickened wall 
(asterisk) without colour Doppler 
flow in the former non-coronary 
cusp region, suggestive of an 
abscess. Former right coronary 
cusp (RCC) imaging is hampered 
by reverberations (arrowhead). b 
CTA confirmed TEE findings but 
also detected an abscess in the 
RCC region (asterisks). Panel c: 
CTA fused with FDG-PET con-
firmed abscesses (asterisks). The 
vegetation (arrow) did not show 
FDG uptake. Additionally, whole 
body FDG-PET/CT showed a 
metastatic infection in the spleen 
(Panel d, arrow), in this case an 
abscess requiring percutaneous 
drainage. Re-printed with permis-
sion [20]
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and FDG-PET. In line with the recently published ESC 
guideline on endocarditis [31], we suggest to add MDCT 
and FDG-PET to the modified Duke criteria in case of PHV 
endocarditis suspicion (Table 1). In patients with already 
proven PHV endocarditis, addition of MDCT may still be 
favourable as it also supplies coronary angiography. From 
a surgical perspective it also provides information about the 
extent of periannular extension which guides the operation 
strategy. Addition of FDG-PET may still be useful when 
PHV endocarditis is already proven as extra-cardiac infec-
tions may be detected (primary/metastatic). Furthermore, 
when only PHV vegetations were detected by TEE, perian-
nular extension may be ruled out or detected by additional 
FDG-PET and/or MDCT. Figure 5 shows a diagnostic algo-
rithm regarding patients with suspected and proven PHV 
endocarditis.
Concomitant coronary angiography
MDCT may replace preoperative invasive coronary angi-
ography, which is not desirable in patients with aortic PHV 
vegetations as mechanical manipulation by an invasive 
catheter may be complicated by distal embolisation. Fur-
thermore, in case of PHV reoperation MDCT provides valu-
able information about the distance between the sternum 
and the right ventricle and also the relation of the sternum 
to bypass grafts if present. In contrast to non-PHV cases 
at angles not previously possible [25]. Two small studies 
investigated the complementary value of 3D-TEE. Both 
studies showed incremental value of 3D-TEE (on top of 2D 
TTE/TEE); however; compared with the reference standard, 
signs of PHV endocarditis were still missed and the number 
of included cases were very low.
Cardiac magnetic resonance imaging
Cardiac MRI is safe beneath a value of 3 T for all mod-
ern PHVs (both biological and mechanical) as no signifi-
cant interruption of valve motion nor overheating have been 
observed [26, 27]. The largest diagnostic problem is severe 
artifacts caused by the PHV resulting in a minimal additional 
imaging role of MRI for PHV endocarditis [28]. However, 
in the detection and quantification of PHV leakage, cardiac 
MRI may have a diagnostic role as phase contrast-based 
analysis can be subvalvular or supravalvular [29, 30].
Proposed imaging strategy
PHV patients with a suspicion of endocarditis should 
undergo TTE and TEE by an experienced sonographer. If 
3D-TEE is available when performing 2D-TEE, one should 
have a low threshold to acquire 3D images of the PHV, at 
least for confirmation of the 2D findings. Patients with a 
high suspicion of PHV endocarditis and negative or incon-
clusive echocardiography should undergo additional MDCT 
Fig. 5 Imaging strategy for sus-
pected PHV endocarditis
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guidelines advocate confirmation of thrombus formation by 
TTE, TEE and fluoroscopy [38]. Although the severity of 
obstruction can be reliably detected by TTE, it is not able 
to detect the exact cause of the obstruction [42]. A gradual 
decrease in effective orifice area suggests pannus; however, 
this information is often not present. Therefore the addition 
of fluoroscopy is advised. When the PHV is significantly 
obstructed and fluoroscopy does not show leaflet restriction, 
thrombolysis is not advised as pannus is confirmed (Table 2 
and Fig. 6). Restriction of both leaflets detected by fluoros-
copy is non-discriminative for pannus or thrombus [43]. 
Therefore ESC guidelines advise to add TEE in order to 
improve diagnostic accuracy. However, TEE assessment is 
hampered by acoustic shadowing caused by the PHV which 
contains metal and obscures adjacent anatomical structures 
for a correct diagnostic assessment. For this reason pannus 
and/or thrombus masses are often missed by 2D-TEE [42–
47]. Only one dedicated study on the additional value of 
3D-TEE in obstructed mechanical mitral PHVs was recently 
published [48]. This study shows that 3D-TEE has addi-
tional value on thrombus detection compared with 2D-TEE, 
but differentiation of thrombus from pannus was not inves-
tigated. Only a few studies have been published investigat-
ing the capability of 2D-TEE on this topic [43, 45, 46]. In 
case of mass detection thrombus/pannus differentiation by 
2D-TEE remains difficult. Echocardiographic predictors for 
pannus/thrombus are shown in Table 2. However, differen-
tiation may be provided more reliably by MDCT (Fig. 6). 
MDCT studies reveal that pannus is attached to the inflow 
site of the PHV ring and presents as a hypodense mass with 
a (semi)circular anatomical configuration curved along the 
[32], non-invasive angiography (MDCT) can be hampered 
by PHV scattering, especially in PHVs containing cobalt 
chrome (Bjork Shiley/Sorin tilting disk/Duromedics bileaf-
let) [33]. Moreover, MDCT protocols for PHV assessment 
use retrospective gating, whereas MDCT primarily per-
formed for coronary assessment uses prospective gating 
and no beta-blockers or nitroglycerin [32, 34, 35] However, 
when conclusive, MDCT has a negative predictive value 
of 100 % compared with invasive coronary angiography 
(CAG) [36]. Following this strategy, in approximately 50 % 
of patients a preoperative CAG is no longer required, reduc-
ing radiation exposure, contrast use and complications. As 
could be expected, in patients with known coronary artery 
disease MDCT is not able to replace CAG.
PHV obstruction
TTE is the first diagnostic screening tool with a good diag-
nostic accuracy for PHV obstruction. Transprosthetic valve 
gradients derived simultaneously by continuous wave Dop-
pler and invasive catheter pressure measurements have a 
good correlation [37]. Biological and mechanical PHVs are 
susceptible to develop obstruction caused by either degen-
eration, pannus or thrombosis (acquired obstruction). In 
contrast to acquired PHV obstruction, patient prosthesis 
mismatch is present directly after the operation in adults. 
In the chronic postoperative phase, this mismatch can be 
differentiated from acquired obstruction by comparison of 
the effective orifice area of the initial postoperative outpa-
tient TTE (around 6 weeks after implantation) and the most 
recent TTE [38]. This underscores the importance of this 
initial postoperative echocardiogram as advised by the ESC 
guidelines. In acquired obstruction the pathological mecha-
nism between biological and mechanical PHVs is different. 
Acquired obstruction in biological PHVs is often calcifying 
degeneration, resulting in leaflet restriction. Theoretically 
another less frequent cause can be pannus formation around 
the stent struts or active endocarditis. The therapeutic con-
sequence of significant obstruction of a biological PHV in 
a symptomatic patient is re-operation if clinically possible 
[38]. Therefore additional diagnostics are not required in 
biological PHV obstructions as they do not change patient 
management. In contrast to biological PHVs, acquired 
mechanical PHV obstruction is not caused by degeneration, 
but mainly by two entities: pannus or thrombus [39]. Differ-
entiation between these causes is important as it may result 
in major therapeutic differences; obstructive thrombosis 
may require fibrinolysis and/or heparin infusion, whereas 
this is strictly contraindicated in obstructive pannus [39–
41]. In clinical practice, the differentiation between obstruc-
tive thrombus and pannus remains challenging though very 
important when fibrinolysis is considered. Clinical param-
eters are not reliable enough to differentiate, therefore ESC 
Table 2 Fluoroscopy/Echocardiography/cardiac MDCT predictors for 
obstructive PHV pannus versus thrombus
Pannus: fluoroscopy predictors Thrombus: fluoroscopy 
predictors
Leaflet restriction mostly present Leaflet restriction always 
present
Leaflet restriction may be absent Total occlusion of one leaflet 
and normal opening of the other 
leaflet (in bileaflet PHVs)
Pannus: echo predictors Thrombus: echo predictors




Absent/small mass on inflow side 
of PHV
Present mass/large mass on 
inflow + outflow side of PHV
Hard echo density Soft echo density
Pannus: MDCT predictors Thrombus: MDCT predictors
Hypodense mass on inflow side 
PHV
Hypodense mass on inflow and 
outflow side PHV
Mass anatomy: (semi)circular 
configuration curved along the 
valve ring
Mass anatomy: irregular shape, 
directly attached to the leaflets/
hinge points
EOA effective orifice area, MDCT multidetector-row computed 
tomography, PHV prosthetic heart valve.
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General conclusion
PHV endocarditis and obstruction remain difficult to diag-
nose correctly by echocardiography alone. As clinical 
implications are major, this paper provides evidence that 
clinicians should have a low threshold to perform additional 
imaging by novel techniques in the field of PHV dysfunc-
tion, such as 3D-TEE, FDG-PET and/or MDCT.
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valve ring. In contrast, obstructive thrombi are imaged as 
supravalvular and subvalvular hypodense masses with 
irregular anatomy directly attached to the leaflets and hinge 
points causing mechanical obstruction by leaflet restriction. 
Theoretically mass differentiation (thrombus versus pan-
nus) may also be possible by determining the Hounsfield 
units, though no convincing evidence is available yet [43]. 
Furthermore MDCT enables visualisation of opening and 
closing kinetics of the PHV using a retrospective protocol 
with a minimum of 10 phases per heart cycle [49]. As out-
lined, MDCT is a promising imaging tool for correct differ-
entiation of pannus from thrombus, however no prospective 
MDCT studies are present yet. Based on currently available 
literature the diagnostic algorithm is proposed as in Fig. 7.
Fig. 6 PHV obstruction case. 
Case 1: a Fluoroscopy; normal 
systolic opening angles of an 
aortic St. Jude mechanical PHV. 
b TEE; showing subprosthetic 
tissue (arrow). c MDCT; showing 
hypodense subvalvular tissue 
(arrow) curved along the PHV 
ring which was pannus confirmed 
by surgery. Case 2: a Fluoros-
copy; both leaflets show systolic 
restriction. b TEE: aortic Tophat 
PHV its acoustic shadowing and 
reverberations (arrow). c MDCT 
shows hypodense subprosthetic 
tissue curved along the PHV ring 
which was pannus confirmed by 
surgery. Case 3: a Both leaflets 
show systolic restriction detected 
by MDCT. b TEE shows an 
oscillating mass at the aortic side 
of the St. Jude PHV. c MDCT 
shows an irregular shaped and 
hypodense mass directly attached 
to the occluder on the ven-
tricular and aortic side which was 
thrombus confirmed by surgery. 
Re-printed with permission [43]
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